Suchergebnisse - "Remes, K"

PubPharm (205)

1

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

enthalten in: Leukemia | 2017

von Kontro, M. | Kumar, A. | Majumder, M. | +14

2

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

enthalten in: Bone marrow transplantation | 2016

von Silvennoinen, R. | Anttila, P. | Säily, M. | +18

CommentIn: Bone Marrow Transplant. 2016 Mar;51(3):348-50. - PMID 26691418

3

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

enthalten in: Bone marrow transplantation | 2016

von Silvennoinen, R. | Anttila, P. | Säily, M. | +18

4

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

enthalten in: Leukemia | 2016

von Kontro, M. | Kumar, A. | Majumder, M. | +14

5

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

enthalten in: Leukemia | 2016

von Kontro, M. | Kumar, A. | Majumder, M. | +14

6

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT

enthalten in: Bone marrow transplantation | 2015

von Grövdal, M. | Nahi, H. | Gahrton, G. | +14

7

Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma

enthalten in: Bone marrow transplantation | 2015

von Oksman, M. | Itälä-Remes, M. | Kauppila, M. | +4

8

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT

enthalten in: Bone marrow transplantation | 2015

von Grövdal, M. | Nahi, H. | Gahrton, G. | +14

9

Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma

enthalten in: Bone marrow transplantation | 2015

von Oksman, M. | Itälä-Remes, M. | Kauppila, M. | +4

10

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

enthalten in: European journal of haematology | 2015

von Hjorth-Hansen, H. | Stenke, L. | Soderlund, S. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]